Key result
Integrated Yoga Therapy significantly improved cardiac autonomic function compared to usual care, evidenced by lower resting heart rate (P<0.02) and improved heart rate variability indices (P<0.001).
Why the study?
Cardiotoxicity with cardiac autonomic dysfunction is a common adverse effect of chemotherapy in breast cancer patients, and integrated yoga therapy was evaluated as an adjuvant approach to protect autonomic nervous system function.
Does Integrated Yoga Therapy improve cardiac autonomic function in breast cancer patients undergoing anthracycline-based adjuvant chemotherapy?
RCT (n=68)
randomly assigned
Does Integrated Yoga Therapy improve cardiac autonomic function in breast cancer patients undergoing anthracycline-based adjuvant chemotherapy?
p-value: p=<0.001
Integrated Yoga Therapy may protect against cardiac autonomic dysfunction in breast cancer patients receiving anthracycline-based chemotherapy.
No takes yet. Share an insight, caveat, or question.
IYT may protect ANS function during BC chemotherapy; extends yoga's cardiac benefits to cardio-oncology.
Inbaraj et al. (2023) conducted an RCT in Breast cancer (n=68). Integrated Yoga Therapy (IYT) vs. Treatment as Usual (TAU) was evaluated on Cardiac autonomic function assessed by resting heart rate (RHR) and heart rate variability (HRV) (p=<0.001). Integrated Yoga Therapy significantly improved cardiac autonomic function compared to usual care, evidenced by lower resting heart rate (P<0.02) and improved heart rate variability indices (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: